Skip to content
WeighLab
Menu
Ranked #33 · Grade C

Gala Health review

Every dose at one published price, with the whole price list visible before you hand over an email — but the only terms it sells on are a yearly subscription at $179 or a three-month plan at $199, so there is no monthly number here to compare with anyone else's.

Visit Gala Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$179/mo (yearly subscription)
Tirzepatide
Not disclosed
Coverage
50 states claimed, no list published
Brand-name
Yes

Semaglutide · modeled / year

$2,148

The Index scorecard

Gala Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month74/100
Price Transparency62/100
Nationwide Access76/100
Formulation Options82/100
Clinical Oversight80/100
Contract Flexibility50/100

Where the value is

  • $179/mo with every dose included, so the price does not climb as you titrate — dose escalation is where most flat-looking programmes quietly get expensive
  • The price list is PUBLIC and un-gated: the weight tier, the $149 microdosing tier and the brand tier are all printed before any quiz, intake or email capture
  • Both compounded molecules — semaglutide and tirzepatide — prescribable on one account
  • LegitScript-verified, with care delivered through OpenLoop-affiliated medical groups rather than an unnamed clinical layer
  • A genuine FDA-approved brand route alongside the compounded line: Ozempic® at "FROM $1,299/month"
  • A women's-health programme in the round — HRT and menopause care sit beside the weight line, which nothing else on this board offers

The tradeoffs

  • No month-to-month price exists anywhere on the site. "FROM $179/month" sits directly above "All doses included. Yearly subscription.", and the cheapest alternative the FAQ names is "$199 per month (with a 3-month plan)" — three months is the shortest published commitment there is
  • $179/mo is $2,148 committed for the year, and that total is printed nowhere: the site quotes a monthly figure for a purchase it only sells annually, which is the single hardest cost on this board to compare against a rate you can cancel next month
  • No tirzepatide price is published at all — "FROM $179" is a floor across the line, so we model no tirzepatide figure for Gala rather than assume one
  • Claims all 50 states but never publishes the list, so coverage cannot be checked before signing up
  • The compounding pharmacy is never named — only "a wide network"
  • No clinician is named either. The site shows Mount Sinai, Harvard and Columbia logos under "trained at", which is a claim about the schooling of people it does not identify
  • Injection only — no oral or sublingual route for the needle-averse
  • The brand tier is Ozempic®, which is brand semaglutide — there is no brand tirzepatide (Zepbound or Mounjaro) route here
  • Marketed squarely as a women's brand ("for Women", "dosed for women's bodies"), which is a real fit caveat on a general-audience board

The bottom line

Best for: Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight programme. Every dose at one published price, with the whole price list visible before you hand over an email — but the only terms it sells on are a yearly subscription at $179 or a three-month plan at $199, so there is no monthly number here to compare with anyone else's.

Ranked #33 of 34 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 33 other providers we've modeled, in Cost-Efficiency Index order.

Every other program we track (30)

Pricing, states and verification reflect Gala Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Gala Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard